UTHSC researcher studies sphingolipid signaling in ocular and neurodegenerative disease and diabetes Dr. Nawajes Mandal has spent his career at the University of Tennessee Health Science Center (UTHSC) trying to better understand lipid and sphingolipid signaling in ocular and neurodegenerative disease and diabetes. One of his current projects may help slow the progression of retinal degeneration, (read more)
UTHSC
UTRF Develops Agreement Enabling Rapid, Long-term Collaboration with Moderna to Fight COVID-19
During the height of the COVID-19 pandemic, the University of Tennessee Research Foundation was hard at work facilitating relationships to connect groundbreaking research from University of Tennessee campuses and institutes with industry need. At the University of Tennessee Health Science Center in Memphis, UTRF entered into a hybrid agreement with Moderna to leverage technology, expertise (read more)
UTRF Inventor Spotlight: Dr. James Dale
UTHSC researcher developing vaccine to help eradicate rheumatic heart disease, saving thousands of lives each year. Anyone who has spent time around children is likely familiar with strep throat, a common bacterial infection treated with antibiotics in high-income countries. However, in low-to-moderate-income parts of the world, this seemingly innocuous infection can become deadly due to (read more)